Regenesance

regenesance.com

Stage

Seed | Alive

About Regenesance

Regenesance is a specialty pharmaceutical company developing drugs to treat acute and chronic nerve disorders.

Regenesance Headquarter Location

Meibergdreef 45 R-Noord 01-152

1105 BA,

Netherlands

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Regenesance Patents

Regenesance has filed 7 patents.

The 3 most popular patent topics include:

Complement system
Clusters of differentiation
Immune system

Application Date	Grant Date	Title	Related Topics	Status
6/16/2017	6/9/2020	Antibodies that bind human c6 and uses thereof	Complement system, Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies	Grant

Application Date	6/16/2017
Grant Date	6/9/2020
Title	Antibodies that bind human c6 and uses thereof
Related Topics	Complement system, Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies
Status	Grant

What is Regenesance's latest funding round?
Regenesance's latest funding round is Seed.
Who are the investors of Regenesance?
Investors of Regenesance include Life Sciences Fund Amsterdam.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

Wells Fargo Success Story

3M Success Story